Jack E. Pace
White & Case (New York)
Lawyer (Partner)
Mr. Pace is a member of White & Case’s Global Competition and Commercial Litigation Practice Groups. He concentrates on complex commercial litigation and counseling in the areas of antitrust and trade regulation. Mr. Pace has extensive experience defending companies in complex, multi-jurisdictional class actions, including those involving claims under the antitrust laws, consumer protection statutes and Title VII. Mr. Pace regularly represents clients in the pharmaceutical, financial services, agricultural and insurance industries. Mr. Pace is an Associate Editor of Antitrust Magazine and regularly publishes articles on antitrust law, class certification and other complex commercial litigation topics. Mr. Pace is a member of White & Case’s Knowledge and Technology Committee and has many years of experience advising clients on e-discovery issues such as document retention policies, document collection and discovery management. Mr. Pace is a member of the Board of Directors of Reach Out and Read of Greater New York, a not-for-profit organization focusing on pediatric literacy. He also serves as liaison in connection with the Firm’s work with inMotion, a not-for-profit organization that provides free legal and social services to low income women in New York City, and supervises the Firm’s pro bono special education cases.
Distinctions
Linked authors
Bryan D. Gant
White & Case (New York)
Mark J. Gidley
White & Case (Washington)
Dan Grossbaum
White & Case (New York)
Andrew Hammond
White & Case (New York)
Scott Hershman
White & Case (New York)
1849 | Conferences
Videos
Articles
1113 Bulletin
87
For the thousands of financial institutions anxiously watching the discontinuation and transition from certain interbank offered rates (“IBORs”), 2020 just got a little less chaotic. On Thursday, October 1, 2020, the United States Department of Justice Antitrust Division issued its highly (...)
17
This article has been nominated for the 2020 Antitrust Writing Awards. Click here to learn more about the Antitrust Writing Awards. On October 7, 2019, California became the first state to enact legislation— Assembly Bill 824 (“AB 824”)—rendering certain pharmaceutical patent litigation settlement (...)
272
In a decision that may reverberate beyond the antitrust context, New York’s highest court - the Court of Appeals - held that the state’s antitrust statute lacks the extraterritorial scope to reach a purely foreign alleged antitrust conspiracy. The decision could have broad implications for (...)
321
According to published reports, the Antitrust Division of the US Department of Justice (DOJ) has opened an investigation into possible collusion among various hedge funds that trade euro contracts. The inquiry comes amid a sharp decline in the value of the euro, which has fallen approximately (...)
104
On May 11, 2009, the Antitrust Division of the Department of Justice (“DOJ”), in a speech by new Assistant Attorney General Christine A. Varney and a press release issued later in the day, formally withdrew the report entitled Competition and Monopoly: Single-Firm Conduct under Section 2 of the (...)
312
As any experienced litigator of complex civil cases can attest, clarifying (and potentially containing) the scope of discovery is a critical task. Regardless of the substantive law at issue, tremendous resources often are required to fulfill the duty to preserve and disclose relevant (...)
